Diabetes News

  • Anti-inflammatory protein promotes healthy gut bacteria to curb obesity
    Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes, both of which are risk factors for cardiovascular disease and other serious conditions. Read more »
  • Research examines mechanisms behind cognitive decline in type 2 diabetes
    Type 2 diabetes has been linked with an increased risk of cognitive dysfunction and dementia, but the underlying mechanisms are uncertain. In a new Diabetic Medicine study, imaging tests revealed that changes in white matter regions of the brain that are indicative of small vessel disease are associated with decreased processing speed (the the time it takes a person to do a mental task) in people with Type 2 diabetes. Also, higher blood pressure and worse kidney function were related to worse cognition. Read more »
  • Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults
    A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease. Read more »
  • Either too much or too little weight gain during pregnancy is associated with adverse outcomes in children aged 7 years
    New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that if a woman gains either too much or too little weight during pregnancy, there are adverse effects in children at 7 years of age. The study is by Professor Wing Hung Tam and Professor Ronald C.W. Ma, at The Chinese University of Hong Kong, Shatin, Hong Kong, and colleagues. Read more »
  • BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults
    In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of Missouri, indicate that the Food and Drug Administration-approved "safe" daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases. Read more »
  • After a century, insulin is still expensive – could DIYers change that?
    Soon after Federick Banting discovered that insulin could be used to treat diabetes in 1921, he sold the patent to the University of Toronto for about a dollar. Banting received the Nobel prize because his discovery meant a life-saving drug could become widely available. Nearly a century later, an American with diabetes can pay as much as US$400 per month for insulin, driving some uninsured patients to desperate and dangerous measures. Clearly, something went wrong. Read more »
  • Research reveals link between immunity, diabetes
    When it comes to diet-induced obesity, your immune system is not always your friend. Read more »
  • Gene tech­no­logy brings more pre­cise in­for­ma­tion on the causes of dia­betes
    The main cause of all forms of diabetes is pancreatic beta-cell dysfunction. Beta cells, found in the pancreatic islets, store and release insulin. Decades of research with animal and cellular models have expanded the knowledge on the molecular mechanisms causing the beta-cells to dysfunction. Diego Balboa's doctoral research now offers a more precise model that employs human pluripotent stem cells. Read more »
  • Want to avoid type 2 diabetes? Eat more whole grains
    (HealthDay)—It may seem counterintuitive, but eating bread, pasta and cereal may actually help prevent type 2 diabetes, as long as those foods are made from whole grains, new research suggests. Read more »
  • Miniaturized HTS assay identifies selective modulators of GPR119 to treat type 2 diabetes
    A novel high throughput screening (HTS) assay compatible with an ion channel biosensor component was used successfully to identify selective and active small molecule modulators of G protein-coupled receptor 119 (GPR119), a promising target for the treatment of type 2 diabetes and related metabolic disorders. The development of this cell-based HTS assay and its miniaturization are described in an article published in ASSAY and Drug Development Technologies. Read more »
  • High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity
    Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose. Read more »
  • Fitness, physical activity and low sedentary time all associated with lower risk of type 2 diabetes
    New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that cardiorespiratory fitness (CRF), high-intensity physical activity (HPA) and low sedentary time (ST) are all associated with a lower risk of type 2 diabetes. The study is by Jeroen van der Velde and Annemarie Koster, Maastricht University, Netherlands, and colleagues. Read more »
  • Following Twitter conversations around hacked diabetes tools to manage blood sugar
    The diabetes online community is leading grassroots efforts focused on accelerating the development, access and adoption of diabetes-related tools to manage the disease. Researchers at University of Utah Health examined the community's online Twitter conversation to understand their thoughts concerning open source artificial pancreas (OpenAPS) technology. The results of this study are available online in the September 10 issue of the Journal of Diabetes Science and Technology. Read more »
  • New evidence to support the importance of psychosocial factors in determining type 2 diabetes risk
    The research findings 'Understanding the complexity of glycaemic health – Systematic bio-psychosocial modelling of fasting glucose in middle-age adults; a DynaHEALTH study' have recently been published in the International Journal of Obesity. Read more »
  • WHO issues recommendations for Tx intensification in T2DM
    (HealthDay)—Recommendations have been developed by the World Health Organization for treatment intensification in type 2 diabetes. The recommendations were published online Sept. 4 in the Annals of Internal Medicine. Read more »
  • Exercise could delay progression of type 1 diabetes when first diagnosed
    The findings of a study led by the University of Birmingham suggests that exercise during the first few months of diagnosis of type 1 diabetes could delay the progression of the condition. Read more »
  • Whole grains one of the most important food groups for preventing type 2 diabetes
    It doesn't matter if it's rye, oats or wheat. As long as it is whole grain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center. The comprehensive study is a strong confirmation of previous research findings on the importance of whole grains for prevention of type 2 diabetes. Read more »
  • Scientists identify hormone link between diabetes and hypertension
    Physician researchers with The Ohio State University College of Medicine at the Wexner Medical Center say increased levels of the hormone aldosterone, already associated with hypertension, can play a significant role in the development of diabetes, particularly among certain racial groups. Read more »
  • Combating constant hunger
    A plant-derived substance widely used in traditional Chinese medicine has demonstrated promising weight loss effects. The findings of a study conducted by scientists at the Helmholtz Zentrum München, a partner of the German Center for Diabetes Research (DZD), have now been published in the journal Diabetes. If this substance called Celastrol also proves effective in clinical trials, it could offer a new option for the treatment of obesity. Read more »
  • Excess cardiac risk varies with age of onset of T1DM
    (HealthDay)—Excess cardiovascular risk varies with age at diagnosis of type 1 diabetes, according to a study published online Aug. 27 in The Lancet. Read more »
Pin It